In vitro activity of tedizolid against 43 species of Nocardia species.

Autor: Toyokawa, Masahiro^1,2,3 (AUTHOR) toyokawa@fmu.ac.jp, Ohana, Noboru² (AUTHOR), Tanno, Daiki^1,2,3 (AUTHOR), Imai, Minako³ (AUTHOR), Takano, Yukiko³ (AUTHOR), Ohashi, Kazutaka³ (AUTHOR), Yamashita, Tomonari⁴ (AUTHOR), Saito, Kyoichi² (AUTHOR), Takahashi, Hiroki^5,6,7 (AUTHOR), Shimura, Hiroki^2,3 (AUTHOR)

Publikováno v: Scientific Reports. 3/4/2024, Vol. 14 Issue 1, p1-10. 10p.

Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan.

Autor: Toyokawa, Masahiro^1,2,3 toyokawa@fmu.ac.jp, Ohana, Noboru², Ueda, Akiko⁴, Imai, Minako³, Tanno, Daiki^2,3, Honda, Mutsuko³, Takano, Yukiko³, Ohashi, Kazutaka³, Saito, Kyoichi², Shimura, Hiroki^2,3

Publikováno v: Scientific Reports. 8/18/2021, Vol. 11 Issue 1, p1-11. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nocardia sputorum sp. nov., an actinobacterium isolated from clinical specimens in Japan.

Autor: Hamada M; Biological Resource Center, National Institute of Technology and Evaluation (NBRC), 2-5-8 Kazusakamatari, Kisarazu, Chiba 292-0818, Japan.; Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8673, Japan., Enomoto N; Biological Resource Center, National Institute of Technology and Evaluation (NBRC), 2-5-8 Kazusakamatari, Kisarazu, Chiba 292-0818, Japan., Yamashita T; MicroSKY Lab, Inc., Center building Kanamachi 2F, 6-6-5 Higashikanamachi, Katsushika-ku, Tokyo 125-0041, Japan., Shimojima M; SUGIYAMAGEN. CO., LTD., 2-34-9 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan., Tanno D; Department of Clinical Laboratory Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima City, Fukushima 960-8516, Japan.; Department of Laboratory Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, Fukushima 960-1295, Japan., Ohana N; Department of Laboratory Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, Fukushima 960-1295, Japan., Toyokawa M; Department of Clinical Laboratory Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima City, Fukushima 960-8516, Japan.; Department of Laboratory Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, Fukushima 960-1295, Japan., Takahashi H; Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8673, Japan.; Molecular Chirality Research Center, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan.; Plant Molecular Science Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan., Yaguchi T; Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8673, Japan.

Publikováno v: International journal of systematic and evolutionary microbiology [Int J Syst Evol Microbiol] 2023 Jun; Vol. 73 (6).

Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells.

Autor: Yamamoto N; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Infection Control, Fukushima Medical University, Hikarigaoka, Japan., Kerfoot SM; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Hutchinson AT; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Dela Cruz CS; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Nakazawa N; Department of Infection Control, Fukushima Medical University, Hikarigaoka, Japan., Szczepanik M; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Medical Biology, Jagiellonian University Medical College, Krakow, Poland., Majewska-Szczepanik M; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Medical Biology, Jagiellonian University Medical College, Krakow, Poland., Nazimek K; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Immunology, Jagiellonian University Medical College, Krakow, Poland., Ohana N; Department of Infection Control, Fukushima Medical University, Hikarigaoka, Japan., Bryniarski K; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Department of Immunology, Jagiellonian University Medical College, Krakow, Poland., Mori T; Department of Infection Control, Fukushima Medical University, Hikarigaoka, Japan., Muramatsu M; Department of Molecular Genetics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan., Kanemitsu K; Department of Infection Control, Fukushima Medical University, Hikarigaoka, Japan., Askenase PW; Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Publikováno v: Immunology [Immunology] 2016 Jan; Vol. 147 (1), pp. 97-113.